Dehlan
Dehlan is the Vice President and General Manager for China at Eli Lilly, a leading American pharmaceutical company. He has been instrumental in the company’s growth and innovation strategies, particularly in the fields of cardiovascular and metabolic health as well as Alzheimer's disease. During the recent 2025 China International Fair for Trade in Services, he highlighted Eli Lilly's commitment to developing innovative medicines and expanding its market presence in China.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| China | 1 | 8.00 | 0.07% | +0% | 1,402,112,000 | 1,031,723 | $14,000,000 | 10,302$ |
| Totals | 1 | 1,402,112,000 | 1,031,723 | $14,000,000 | 10,302$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
China:
Dehlan, the Vice President and General Manager of Eli Lilly China, expressed the company's commitment to developing innovative drugs and participating in local innovation ecosystems.
8